LRRK1 and acute lymphoblastic leukemia: To conclude, we testified that LINC00511 exacerbated T-ALL cell proliferation and inhibited cell apoptosis via miR-195-5p/LRRK1 axis, which implies a potential biomarker of T-ALL treatment.